| LETTER TO THE EDITOR |
|
| Year : 2020 | Volume
: 7
| Issue : 2 | Page : 106-107 |
|
|
Bleomycin-induced flagellate dermatitis
Abheek Sil, Dibyendu B Bhanja, Sayantani Chakraborty
Department of Dermatology, Venereology, and Leprosy, R.G. Kar Medical College, Kolkata, West Bengal, India
Correspondence Address:
Dr. Abheek Sil
Department of Dermatology, Venereology, and Leprosy, R.G. Kar Medical College, 1, Khudiram Bose Sarani, Kolkata 700004
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/Pigmentinternational.Pigmentinternational_
|
|
|
Flagellate pigmentation represents a unique adverse effect of bleomycin therapy that is encountered in 8–22% of patients. But this occurrence is independent of dose, route of administration, and underlying disorder (including type of malignancy). We highlight a case of a middle-aged man who developed flagellate hyperpigmentation following bleomycin-containing combined chemotherapy for Hodgkin’s lymphoma. Early recognition of bleomycin as the culprit drug is of paramount importance as these patients are usually on multiple medications.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
